These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15504767)

  • 1. Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry.
    Wazana A; Granich A; Primeau F; Bhanji NH; Jalbert M
    Acad Med; 2004 Nov; 79(11):1033-40. PubMed ID: 15504767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
    Chakrabarti A; Fleisher WP; Staley D; Calhoun L
    Ann R Coll Physicians Surg Can; 2002 Dec; 35(8 Suppl.):541-6. PubMed ID: 15015500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the pharmaceutical industry in teaching psychopharmacology: a growing problem.
    Brodkey AC
    Acad Psychiatry; 2005; 29(2):222-9. PubMed ID: 15937271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
    Razack S; Arbour L; Hutcheon R
    Ann R Coll Physicians Surg Can; 1999 Mar; 32(2):93-6. PubMed ID: 12378718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between emergency medicine programs and the pharmaceutical industry.
    Keim SM; Mays MZ; Grant D
    Acad Emerg Med; 2004 Jan; 11(1):19-26. PubMed ID: 14709424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of residency program guidelines for interaction with the pharmaceutical industry. Education Council, Residency Training Programme in Internal Medicine, Department of Medicine, McMaster University, Hamilton, Ont.
    CMAJ; 1993 Aug; 149(4):405-8. PubMed ID: 8348422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposed guidelines for housestaff interaction with pharmaceutical companies.
    Forrest DM; Ruedy J
    Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing.
    Agrawal S; Saluja I; Kaczorowski J
    Acad Med; 2004 Nov; 79(11):1046-50. PubMed ID: 15504769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What residents don't know about physician-pharmaceutical industry interactions.
    Watkins RS; Kimberly J
    Acad Med; 2004 May; 79(5):432-7. PubMed ID: 15107282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Attitudes and behaviors of psychiatry residents and psychiatrists working in training institutes towards the relationship between the pharmaceutical industry and physicians].
    Gülöksüz S; Oral ET; Ulaş H
    Turk Psikiyatri Derg; 2009; 20(3):236-42. PubMed ID: 19757223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
    Sergeant MD; Hodgetts PG; Godwin M; Walker DM; McHenry P
    CMAJ; 1996 Nov; 155(9):1243-8. PubMed ID: 8911290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
    Misra S; Ganzini L; Keepers G
    Acad Psychiatry; 2010; 34(2):102-8. PubMed ID: 20224017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical representatives and emergency medicine residents: a national survey.
    Reeder M; Dougherty J; White LJ
    Ann Emerg Med; 1993 Oct; 22(10):1593-6. PubMed ID: 8214843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy residents' attitudes toward pharmaceutical industry promotion.
    Ashker S; Burkiewicz JS
    Am J Health Syst Pharm; 2007 Aug; 64(16):1724-31. PubMed ID: 17687062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Industry relations with emergency medicine graduate medical education programs.
    Kowalenko T; Char D; Marco C; Asher S; Raja A; Farrell S; Sokolove PE;
    Acad Emerg Med; 2009 Oct; 16(10):1025-30. PubMed ID: 19799581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policies regulating the activities of pharmaceutical representatives in residency programs.
    Brotzman GL; Mark DH
    J Fam Pract; 1992 Jan; 34(1):54-7. PubMed ID: 1728655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The updated AMSA scorecard of conflict-of-interest policies: a survey of U.S. medical schools.
    Carlat DJ; Fagrelius T; Ramachandran R; Ross JS; Bergh S
    BMC Med Educ; 2016 Aug; 16(1):202. PubMed ID: 27519253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians.
    Brett AS; Burr W; Moloo J
    Arch Intern Med; 2003 Oct; 163(18):2213-8. PubMed ID: 14557219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.